Evidence map›Paper›PMID 33608279›Full record

ArticleScience advances2021

Model-guided design of mammalian genetic programs.

J J Muldoon, V Kandula, M Hong, P S Donahue, J D Boucher, N Bagheri, J N Leonard

Abstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Programming Next-Generation Synthetic Biosensors by Genetic Circuit Design.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The evolution of synthetic receptor systems.Nature chemical biology · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

J J MuldoonInterdisciplinary Biological Sciences Program, Northwestern University, Evanston, IL 60208, USA.ORCID 0000-0003-3784-3565
V KandulaHonors Program in Medical Education, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.ORCID 0000-0002-2245-5845
M HongDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, IL 60208, USA.ORCID 0000-0001-6175-3143
P S DonahueInterdisciplinary Biological Sciences Program, Northwestern University, Evanston, IL 60208, USA.ORCID 0000-0003-1415-6113
J D BoucherInterdisciplinary Biological Sciences Program, Northwestern University, Evanston, IL 60208, USA.ORCID 0000-0001-6938-4813
N BagheriInterdisciplinary Biological Sciences Program, Northwestern University, Evanston, IL 60208, USA.ORCID 0000-0003-0146-4627
J N LeonardInterdisciplinary Biological Sciences Program, Northwestern University, Evanston, IL 60208, USA. j-leonard@northwestern.edu.ORCID 0000-0003-4359-6126

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008152 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 1987 to 2021
$24.0M
Medical Scientist Training ProgramT32GM144295 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ALAN R HAUSER · 2022 to 2026
$9.1M
Design-driven engineering of robust mammalian sense-and-respond functions: from parts to programsR01EB026510 · NIBIB · NORTHWESTERN UNIVERSITY · PI Neda Bagheri, Joshua Nathaniel Leonard · 2018 to 2026
$3.7M
Therapeutic and Sustained Cytokine Delivery at the Tumor Site Using Engineered Mononuclear CellsF30CA203325 · NCI · NORTHWESTERN UNIVERSITY · PI DONAHUE, PATRICK SEAN · 2016 to 2019
$186k
NCI NIH HHS F30 CA203325NCI NIH HHS P30 CA060553NIBIB NIH HHS R01 EB026510NIGMS NIH HHS T32 GM008152NIGMS NIH HHS T32 GM144295
6 · The paper itself

Abstract

Genetically engineering cells to perform customizable functions is an emerging frontier with numerous technological and translational applications. However, it remains challenging to systematically engineer mammalian cells to execute complex functions. To address this need, we developed a method enabling accurate genetic program design using high-performing genetic parts and predictive computational models. We built multifunctional proteins integrating both transcriptional and posttranslational control, validated models for describing these mechanisms, implemented digital and analog processing, and effectively linked genetic circuits with sensors for multi-input evaluations. The functional modularity and compositional versatility of these parts enable one to satisfy a given design objective via multiple synonymous programs. Our approach empowers bioengineers to predictively design mammalian cellular functions that perform as expected even at high levels of biological complexity.

Identifiers

PMID33608279
PMCPMC7895425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.